Last reviewed · How we verify
Target controlled infusion of propofol — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Target controlled infusion of propofol (Target controlled infusion of propofol) — Brugmann University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Target controlled infusion of propofol TARGET | Target controlled infusion of propofol | Brugmann University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Target controlled infusion of propofol CI watch — RSS
- Target controlled infusion of propofol CI watch — Atom
- Target controlled infusion of propofol CI watch — JSON
- Target controlled infusion of propofol alone — RSS
Cite this brief
Drug Landscape (2026). Target controlled infusion of propofol — Competitive Intelligence Brief. https://druglandscape.com/ci/target-controlled-infusion-of-propofol. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab